Red Blood Cell Depletion in Patients With Hyperferritinemia: Comparison of Two Apheresis Systems

Fuente: Wiley Open Access
Guardado en:
Detalles Bibliográficos
Autores principales: Heidrun Neureiter, Nadja Schroeder, Orkan Kartal, Sandra Laner‐Plamberger, Wanda Lauth, Eva Rohde, Christoph Grabmer
Formato: Artículo Open Access
Publicado: Wiley 2026
Materias:
Acceso en línea:
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
_version_ 1867015925576761344
author Heidrun Neureiter
Nadja Schroeder
Orkan Kartal
Sandra Laner‐Plamberger
Wanda Lauth
Eva Rohde
Christoph Grabmer
author_facet Heidrun Neureiter
Nadja Schroeder
Orkan Kartal
Sandra Laner‐Plamberger
Wanda Lauth
Eva Rohde
Christoph Grabmer
Heidrun Neureiter
Nadja Schroeder
Orkan Kartal
Sandra Laner‐Plamberger
Wanda Lauth
Eva Rohde
Christoph Grabmer
collection Wiley Open Access
contents Red Blood Cell Depletion in Patients With Hyperferritinemia: Comparison of Two Apheresis Systems Heidrun Neureiter Nadja Schroeder Orkan Kartal Sandra Laner‐Plamberger Wanda Lauth Eva Rohde Christoph Grabmer Journal of Clinical Apheresis ABSTRACT Red blood cell (RBC) apheresis is, alongside phlebotomy, a standard treatment for iron overload in hereditary hemochromatosis (HH). We compared the serum ferritin (SF) reduction, process parameters, duration, and side effects of two apheresis systems: Spectra Optia apheresis system (Optia) and Alyx apheresis collection system (Alyx). Forty‐three patients were RBC depleted with one of the two separators, Optia or Alyx. In total, 186 procedures were performed. The main diagnoses were HH ( n  = 20) and dysmetabolic iron overload syndrome (DIOS) ( n  = 21). Around two thirds of the procedures were done with Optia ( n  = 143) and one third with Alyx ( n  = 43). A mean volume of 405 and 442 mL of RBCs was withdrawn per single treatment with the Optia and Alyx, respectively. The procedure took 12 min (Optia) versus 26 min (Alyx) with a hematocrit (Hct) reduction of 5% versus 7.5% ( p  < 0.001). The SF reduction 3 weeks after RBC depletion was not significantly different between the two systems. The amount of anticoagulant used with the Optia was almost half of what was used with the Alyx (63 mL compared to 123 mL). There were no significant adverse events. The advantages of the Alyx include the lower cost and the easy portability. The Optia, on the other hand, has a shorter procedure time, a smaller extracorporeal volume, a lower anticoagulant consumption, a lower rate of complications, and allows a precise Hct adjustment. 10.1002/jca.70097 http://creativecommons.org/licenses/by/4.0/
doi_str_mv 10.1002/jca.70097
format Artículo Open Access
id wiley_oa_10_1002_jca_70097
institution Wiley Open Access
license_str_mv http://creativecommons.org/licenses/by/4.0/
publishDate 2026
publisher Wiley
record_format wiley_oa
spellingShingle Red Blood Cell Depletion in Patients With Hyperferritinemia: Comparison of Two Apheresis Systems
Heidrun Neureiter
Nadja Schroeder
Orkan Kartal
Sandra Laner‐Plamberger
Wanda Lauth
Eva Rohde
Christoph Grabmer
Journal of Clinical Apheresis
Red Blood Cell Depletion in Patients With Hyperferritinemia: Comparison of Two Apheresis Systems Heidrun Neureiter Nadja Schroeder Orkan Kartal Sandra Laner‐Plamberger Wanda Lauth Eva Rohde Christoph Grabmer Journal of Clinical Apheresis ABSTRACT Red blood cell (RBC) apheresis is, alongside phlebotomy, a standard treatment for iron overload in hereditary hemochromatosis (HH). We compared the serum ferritin (SF) reduction, process parameters, duration, and side effects of two apheresis systems: Spectra Optia apheresis system (Optia) and Alyx apheresis collection system (Alyx). Forty‐three patients were RBC depleted with one of the two separators, Optia or Alyx. In total, 186 procedures were performed. The main diagnoses were HH ( n  = 20) and dysmetabolic iron overload syndrome (DIOS) ( n  = 21). Around two thirds of the procedures were done with Optia ( n  = 143) and one third with Alyx ( n  = 43). A mean volume of 405 and 442 mL of RBCs was withdrawn per single treatment with the Optia and Alyx, respectively. The procedure took 12 min (Optia) versus 26 min (Alyx) with a hematocrit (Hct) reduction of 5% versus 7.5% ( p  < 0.001). The SF reduction 3 weeks after RBC depletion was not significantly different between the two systems. The amount of anticoagulant used with the Optia was almost half of what was used with the Alyx (63 mL compared to 123 mL). There were no significant adverse events. The advantages of the Alyx include the lower cost and the easy portability. The Optia, on the other hand, has a shorter procedure time, a smaller extracorporeal volume, a lower anticoagulant consumption, a lower rate of complications, and allows a precise Hct adjustment. 10.1002/jca.70097 http://creativecommons.org/licenses/by/4.0/
title Red Blood Cell Depletion in Patients With Hyperferritinemia: Comparison of Two Apheresis Systems
topic Journal of Clinical Apheresis
url https://onlinelibrary.wiley.com/doi/10.1002/jca.70097